药易购：11月18日召开董事会会议

Group 1 - The core point of the article is that Yaoyigou (SZ 300937) announced the convening of its fourth board meeting on November 18, 2025, to discuss a capital increase for its subsidiary and related transactions [1] - For the first half of 2025, the revenue composition of Yaoyigou is as follows: pharmaceutical distribution (contract distribution + market comparison) accounts for 47.09%, pharmaceutical sales (direct procurement) accounts for 41.92%, pharmaceutical manufacturing and OEM business accounts for 8.55%, and other businesses account for 2.44% [1] - As of the report date, Yaoyigou has a market capitalization of 3.1 billion yuan [1]